NEW YORK (GenomeWeb News) - Genomic Health plans to sell 3 million shares of its common stock through an underwritten public offering, the company said yesterday.
 
The company said it will use the proceeds from the sale for general corporate purposes, marketing, R&D, and for expanding its labs.
 
Genomic Health said it will grant underwriters a 30-day option to buy an additional 450,000 shares.
 
The company's stock closed at $15.79 on Monday.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.